Wk 1 & 2 FDA Indications

Lisinopril

Indications include hypertension, heart failure with reduced ejection fraction (HFrEF), and acute myocardial infarction.

Lisinopril/HCTZ

Indication for hypertension.

Benazepril

Indication for hypertension.

Enalapril

Indications include hypertension and heart failure with reduced ejection fraction (HFrEF).

Losartan

Indications include hypertension and diabetic nephropathy (proteinuria chronic kidney disease).

Losartan/HCTZ

Indications include hypertension and hypertension with left ventricular hypertrophy.

Valsartan

Indications include hypertension, heart failure with reduced ejection fraction (HFrEF), and myocardial infarction.

Valsartan/HCTZ

Indication for hypertension.

Olmesartan

Indication for hypertension.

Irbesartan

Indications include hypertension and diabetic nephropathy.

Sacubitril/Valsartan

Indication for heart failure.

Furosemide

Indication for edema or volume overload.

Torsemide

Indications include edema or volume overload; hypertension when hypertension is from edema.

Bumetanide

Indication for edema or volume overload.

Hydrochlorothiazide

Indications include hypertension and mild edema.

Chlorthalidone

Indications include hypertension and mild edema.

Triamterene/HCTZ

Indications include hypertension and mild edema.

Spironolactone

Indications include hypertension, HFrEF, ascites due to cirrhosis, and primary hyperaldosteronism.